BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 2004939)

  • 1. Low-dose craniospinal radiation therapy for medulloblastoma.
    Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy.
    Wara WM; Le QT; Sneed PK; Larson DA; Prados MD; Levin VA; Edwards MS; Weil MD
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):551-6. PubMed ID: 7928485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
    Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P
    J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results for 149 medulloblastoma patients from one institution.
    Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protracted radiotherapy treatment duration in medulloblastoma.
    Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
    Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
    Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
    Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
    Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
    Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma in adults: treatment results and prognostic factors.
    Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma: the Duke University Medical Center experience.
    Hershatter BW; Halperin EC; Cox EB
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1771-7. PubMed ID: 3759529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
    Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
    Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniospinal radiotherapy in adult medulloblastoma.
    Selek U; Zorlu F; Hurmuz P; Cengiz M; Turker A; Soylemezoglu F; Gurkaynak M
    Strahlenther Onkol; 2007 May; 183(5):236-40. PubMed ID: 17497094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
    Kiltie AE; Lashford LS; Gattamaneni HR
    Med Pediatr Oncol; 1997 May; 28(5):348-54. PubMed ID: 9121399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of radiation therapy for medulloblastoma].
    Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.